Insider Trading disclosures for Nephros Inc

The latest disclosure was made by Judith F. Krandel in Nephros Inc where a trade of 54,359 Stock Option (right to buy) done was reported to US exchanges on March 27, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Judith F. Krandel	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Mar 2025	54,359	54,359	-		-	Stock Option (right to buy)
Arthur H. Amron	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2025	22,418	125,881 (1%)	0%		0	Common Stock
Arthur H. Amron	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2025	7,050	7,050	-		-	Stock Option (Right to Buy)
Oliver Spandow	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2025	7,050	7,050	-		-	Stock Option (Right to Buy)
Oliver Spandow	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2025	33,241	114,845 (1%)	0%		0	Common Stock
Alisa Lask	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2025	7,050	7,050	-		-	Stock Option (right to buy)
Joseph Michael Harris	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2025	7,050	7,050	-		-	Stock Option (right to buy)
Arthur H. Amron	Director	Purchase of securities on an exchange or from another person at price $ 2.22 per share.	28 May 2024	2,000	100,463 (1%)	0%	2.2	4,441	Common Stock
Arthur H. Amron	Director	Purchase of securities on an exchange or from another person at price $ 2.24 per share.	28 May 2024	3,000	103,463 (1%)	0%	2.2	6,735	Common Stock
Arthur H. Amron	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 May 2024	7,323	7,323	-		-	Stock Option (Right to Buy)
Oliver Spandow	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 May 2024	7,323	7,323	-		-	Stock Option (Right to Buy)
Alisa Lask	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 May 2024	7,323	7,323	-		-	Stock Option (right to buy)
Joseph Michael Harris	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 May 2024	7,323	7,323	-		-	Stock Option (right to buy)
Robert Banks	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 May 2024	10,406	10,406	-		-	Stock Option (right to buy)
Robert Banks	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 2.24 per share.	14 May 2024	50,000	70,000 (0%)	0%	2.2	112,050	Common Stock
Arthur H. Amron	Director	Purchase of securities on an exchange or from another person at price $ 2.45 per share.	12 Mar 2024	7,000	7,000 (0%)	0%	2.4	17,130	Common stock
Arthur H. Amron	Director	Other type of transaction at price $ 0.00 per share.	12 Mar 2024	91,463	98,463 (1%)	1%		0	Common stock
Amron H. Arthur	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Dec 2023	9,291	9,291 (0%)	0%		0	Common Stock
Harris Michael Joseph	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Dec 2023	9,291	17,693 (0%)	0%		0	Common Stock
Alisa Lask	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Dec 2023	9,291	48,629 (0%)	0%		0	Common Stock
Oliver Spandow	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Dec 2023	14,294	81,604 (0%)	0%		0	Common Stock
Robert Banks	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 2.20 per share.	07 Dec 2023	18,000	20,000 (0%)	0%	2.2	39,647	Common Stock
F. Krandel Judy	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Nov 2023	122,524	122,524	-		-	Stock Option (right to buy)
Robert Banks	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 1.51 per share.	14 Aug 2023	99	99 (0%)	0%	1.5	149	Common Stock
Robert Banks	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 1.69 per share.	14 Aug 2023	1,901	2,000 (0%)	0%	1.7	3,207	Common Stock
Arthur H. Amron	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2023	27,613	27,613 (0%)	0%		0	Common Stock
Arthur H. Amron	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2023	7,080	7,080	-		-	Stock Option (Right to Buy)
Oliver Spandow	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2023	7,080	7,080	-		-	Stock Option (Right to Buy)
Oliver Spandow	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2023	42,481	67,310 (0%)	0%		0	Common Stock
Alisa Lask	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2023	7,080	7,080	-		-	Stock Option (right to buy)
Alisa Lask	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2023	27,613	39,338 (0%)	0%		0	Common Stock
Thomas Gwydir	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2023	7,080	7,080	-		-	Stock Option (right to buy)
Thomas Gwydir	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2023	27,613	43,226 (0%)	0%		0	Common Stock
Joseph Michael Harris	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2023	8,402	8,402 (0%)	0%		0	Common Stock
Joseph Michael Harris	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2023	7,080	7,080	-		-	Stock Option (right to buy)
Joseph Michael Harris	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Sep 2022	13,115	13,115	-		-	Stock Option (right to buy)
Andrew Astor	Director, President, CEO & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.70 per share.	05 Mar 2022	14,815	92,773 (1%)	0%	2.7	40,001	Common Stock
Andrew Astor	Director, President, CEO & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Mar 2022	14,815	0	-		-	Warrants (right to buy)
Wesley S. Lobo	Chief Marketing Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.80 per share.	16 Feb 2022	6,389	35,168 (0%)	0%	4.8	30,667	Common Stock
Arthur H. Amron	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2021	7,062	7,062	-		-	Stock Option (Right to Buy)
Arthur H. Amron	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2021	4,582	4,582 (0%)	0%		0	Common Stock
Andrew Astor	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2021	38,612	38,612	-		-	Stock Option (right to buy)
Oliver Spandow	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2021	5,429	24,829 (0%)	0%		0	Common Stock
Oliver Spandow	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2021	7,062	7,062	-		-	Stock Option (Right to Buy)
Alisa Lask	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2021	7,062	7,062	-		-	Stock Option (right to buy)
Alisa Lask	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2021	4,582	11,725 (0%)	0%		0	Common Stock
Thomas Gwydir	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2021	7,062	7,062	-		-	Stock Option (right to buy)
Thomas Gwydir	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2021	4,582	15,613 (0%)	0%		0	Common Stock
Wesley S. Lobo	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Sep 2021	57,368	57,368	-		-	Stock Option (right to buy)
Wesley S. Lobo	Chief Marketing Officer	Purchase of securities on an exchange or from another person at price $ 7.92 per share.	20 Aug 2021	1,000	41,557 (0%)	0%	7.9	7,920	Common Stock

Showing 1 to 50 of 364 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

29.02% Fall from 52W High

Insider Trading disclosures for Nephros Inc

The latest disclosure was made by Judith F. Krandel in Nephros Inc where a trade of 54,359 Stock Option (right to buy) done was reported to US exchanges on March 27, 2025.

Screeners based on Insider Trading and SAST parameters